185 related articles for article (PubMed ID: 31857132)
1. Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study.
Ebert H; Lacruz ME; Kluttig A; Simm A; Greiser KH; Tiller D; Kartschmit N; Mikolajczyk R
Exp Gerontol; 2020 Mar; 131():110815. PubMed ID: 31857132
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products and their ratio to soluble receptor are associated with limitations in physical functioning only in women: results from the CARLA cohort.
Ebert H; Lacruz ME; Kluttig A; Simm A; Greiser KH; Tiller D; Kartschmit N; Mikolajczyk R
BMC Geriatr; 2019 Nov; 19(1):299. PubMed ID: 31684879
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.
Semba RD; Ferrucci L; Sun K; Beck J; Dalal M; Varadhan R; Walston J; Guralnik JM; Fried LP
Aging Clin Exp Res; 2009 Apr; 21(2):182-90. PubMed ID: 19448391
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of soluble Receptor for Advanced Glycation End-products (RAGE) are associated with a higher risk of mortality in frail older adults.
Butcher L; Carnicero JA; Gomez Cabrero D; Dartigues JF; Pérès K; Garcia-Garcia FJ; Rodriguez-Mañas L; Erusalimsky JD;
Age Ageing; 2019 Sep; 48(5):696-702. PubMed ID: 31211360
[TBL] [Abstract][Full Text] [Related]
5. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
[TBL] [Abstract][Full Text] [Related]
6. Soluble form of receptor for advanced glycation end products and incidence of new cardiovascular events among patients with cardiovascular disease.
Reichert S; Triebert U; Santos AN; Hofmann B; Schaller HG; Schlitt A; Schulz S
Atherosclerosis; 2017 Nov; 266():234-239. PubMed ID: 28864204
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
Farhan SS; Hussain SA
Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study.
Sabbatinelli J; Castiglione S; Macrì F; Giuliani A; Ramini D; Vinci MC; Tortato E; Bonfigli AR; Olivieri F; Raucci A
Cardiovasc Diabetol; 2022 Jun; 21(1):95. PubMed ID: 35668468
[TBL] [Abstract][Full Text] [Related]
10. Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
Nin JW; Jorsal A; Ferreira I; Schalkwijk CG; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
Diabetes; 2010 Aug; 59(8):2027-32. PubMed ID: 20522598
[TBL] [Abstract][Full Text] [Related]
11. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
12. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
Prasad K
Mol Cell Biochem; 2019 Jan; 451(1-2):139-144. PubMed ID: 29961210
[TBL] [Abstract][Full Text] [Related]
13. Frailty Influences the Relationship between the Soluble Receptor for Advanced Glycation-End Products and Mortality in Older Adults with Diabetes Mellitus.
Butcher L; Carnicero JA; Pérès K; Bandinelli S; García-García FJ; Rodriguez-Artalejo F; Rodriguez-Mañas L; Erusalimsky JD
Gerontology; 2024; 70(6):585-594. PubMed ID: 38593754
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
[TBL] [Abstract][Full Text] [Related]
15. Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis.
Machahua C; Montes-Worboys A; Planas-Cerezales L; Buendia-Flores R; Molina-Molina M; Vicens-Zygmunt V
Respir Res; 2018 Nov; 19(1):215. PubMed ID: 30409203
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.
Jiao L; Taylor PR; Weinstein SJ; Graubard BI; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1430-8. PubMed ID: 21527578
[TBL] [Abstract][Full Text] [Related]
17. Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients.
Jung ES; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
J Korean Med Sci; 2017 Jan; 32(1):54-59. PubMed ID: 27914132
[TBL] [Abstract][Full Text] [Related]
18. High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality.
Grauen Larsen H; Marinkovic G; Nilsson PM; Nilsson J; Engström G; Melander O; Orho-Melander M; Schiopu A
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):925-933. PubMed ID: 30917679
[TBL] [Abstract][Full Text] [Related]
19. The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.
Grauen Larsen H; Yndigegn T; Marinkovic G; Grufman H; Mares R; Nilsson J; Goncalves I; Schiopu A
Atherosclerosis; 2019 Aug; 287():16-23. PubMed ID: 31181415
[TBL] [Abstract][Full Text] [Related]
20. Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition.
Paradela-Dobarro B; Fernández-Trasancos Á; Bou-Teen D; Eiras S; González-Ferreiro R; Agra RM; Varela-Román A; Castro-Pais AI; Carreira MC; Casanueva FF; Álvarez E; González-Juanatey JR
Cardiovasc Diabetol; 2017 Sep; 16(1):115. PubMed ID: 28915840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
